Cargando…
Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants
BACKGROUND: Point-of-care testing (POCT) of coagulation has been proven to be of great value in accelerating emergency treatment. Specific POCT for direct oral anticoagulants (DOAC) is not available, but the effects of DOAC on established POCT have been described. We aimed to determine the diagnosti...
Autores principales: | Ebner, Matthias, Birschmann, Ingvild, Peter, Andreas, Spencer, Charlotte, Härtig, Florian, Kuhn, Joachim, Blumenstock, Gunnar, Zuern, Christine S., Ziemann, Ulf, Poli, Sven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309971/ https://www.ncbi.nlm.nih.gov/pubmed/28196509 http://dx.doi.org/10.1186/s13054-017-1619-z |
Ejemplares similares
-
Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis
por: Ebner, Matthias, et al.
Publicado: (2018) -
Specific Point-of-Care Testing of Coagulation in Patients Treated with Dabigatran
por: Härtig, Florian, et al.
Publicado: (2021) -
Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban
por: Härtig, Florian, et al.
Publicado: (2021) -
Point-of-care testing of coagulation in patients treated with edoxaban
por: Härtig, Florian, et al.
Publicado: (2020) -
UPLC-MRM Mass Spectrometry Method for Measurement of the Coagulation Inhibitors Dabigatran and Rivaroxaban in Human Plasma and Its Comparison with Functional Assays
por: Kuhn, Joachim, et al.
Publicado: (2015)